Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Historisch | Analysen |
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Nachrichten zu CELLECTISAct. Nom.
25.02.19
|
|
10.12.18
|
|
13.11.18
|
|
19.09.18
|
|
18.09.18
|
|
02.08.18
|
|
01.08.18
|
|
27.06.18
|
|
12.06.18
|
|
04.06.18
|
FDA Grants Cellectis IND Approval for UCART22 in B-ALL (Businesswire)
|
23.05.18
|
|
22.05.18
|
|
21.05.18
|
|
15.05.18
|
Calyxt Announces Launch of Proposed Follow-On Offering (Businesswire)
|
10.05.18
|
Cellectis to Present Data at the 2018 ASGCT Annual Meeting (Businesswire)
|
07.05.18
|
Cellectis Reports 1st Quarter 2018 Financial Results (Businesswire)
|
02.05.18
|
|
01.05.18
|
|
11.04.18
|
Cellectis to Present Data at the 2018 AACR Annual Meeting (Businesswire)
|
10.04.18
|
Cellectis Announces Closing of Follow-On Offering (Businesswire)
|
05.04.18
|
Cellectis Announces Pricing of Follow-On Offering (Businesswire)
|
03.04.18
|
Cellectis Announces Launch of Follow-On Offering (Businesswire)
|
03.04.18
|
|
13.03.18
|
|
12.03.18
|
|
08.03.18
|
|
13.02.18
|
|
06.02.18
|
|
08.01.18
|
|
02.01.18
|
|
13.12.17
|
|
04.12.17
|
|
04.12.17
|
|
04.12.17
|
|
20.11.17
|
|
13.11.17
|
|
08.11.17
|
|
07.11.17
|
|
01.11.17
|
|
01.11.17
|
|
04.10.17
|
|
04.10.17
|
|
07.09.17
|
|
05.09.17
|
Cellectis to Participate in Upcoming Investor Conferences (Businesswire)
|
05.09.17
|
Cellectis Reports Clinical Hold of UCART123 Studies (Businesswire)
|
17.08.17
|
|
02.08.17
|
|
02.08.17
|
|
25.07.17
|
|
24.07.17
|
Cellectis Granted Patent for CRISPR Use in T-Cells (Businesswire)
|